Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer: An Emerging Paradigm?

Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy

(2012) Ching-Wei D. Tzeng et al.   ANNALS OF SURGICAL ONCOLOGY

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators

(2012) Matthew H. G. Katz et al.   CANCER

Results of a Multicenter Randomized Phase II Trial of Resection ± Neoadjuvant Chemoradiation Therapy in Pancreatic Cancer

(2012) T. Brunner et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?

(2012) Katia T. Papalezova et al.   JOURNAL OF SURGICAL ONCOLOGY

Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation

(2012) E Fokas et al.   Cell Death & Disease

Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy

(2011) Erkan Topkan et al.   BMC GASTROENTEROLOGY

Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma

(2011) Deyali Chatterjee et al.   CANCER

Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation ofSmad4(Dpc4)Immunostaining With Pattern of Disease Progression

(2011) Christopher H. Crane et al.   JOURNAL OF CLINICAL ONCOLOGY

Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: A meta-analysis

(2011) Chang-Peng Zhu et al.   RADIOTHERAPY AND ONCOLOGY

Neoadjuvant therapy in pancreatic adenocarcinoma: A meta-analysis of phase II trials

(2011) M. Mura Assifi et al.   SURGERY

Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages

(2010) Sonja Gillen et al.   PLOS MEDICINE

Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review

(2009) R. Le Scodan et al.   ANNALS OF ONCOLOGY

Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement

(2009) Mark P. Callery et al.   ANNALS OF SURGICAL ONCOLOGY

DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer

(2009) Christine A. Iacobuzio-Donahue et al.   JOURNAL OF CLINICAL ONCOLOGY

Current Oncological Treatment of Patients with Pancreatic Cancer in Germany: Results from a National Survey on behalf of the Arbeitsgemeinschaft Internistische Onkologie and the Chirurgische Arbeitsgemeinschaft Onkologie of the Germany Cancer Society

(2009) Stefan Boeck et al.   ONCOLOGY

Downstaging of Pancreatic Carcinoma after Neoadjuvant Chemoradiation

(2009) Dominik Tinkl et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Neoadjuvant Chemotherapy Generates a Significant Tumor Response in Resectable Pancreatic Cancer Without Increasing Morbidity

(2008) Stefan Heinrich et al.   ANNALS OF SURGERY

Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy

(2008) H. Golcher et al.   EJSO

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Phase I Trial of the Human Immunodeficiency Virus Protease Inhibitor Nelfinavir and Chemoradiation for Locally Advanced Pancreatic Cancer

(2008) Thomas B. Brunner et al.   JOURNAL OF CLINICAL ONCOLOGY

Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

(2008) Douglas B. Evans et al.   JOURNAL OF CLINICAL ONCOLOGY

Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease

(2008) Matthew H.G. Katz et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS